Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas

Anja Roden, Eunhee S. Yi, Sarah M. Jenkins, Janis L. Donovan, Stephen D. Cassivi, Yolanda Isabel Garces, Randolph Stuart Marks, Marie Christine Aubry

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The prognostic importance of histologic classifications of thymic epithelial neoplasms is controversial. Evidence suggests that difficulties in reproducibility affect prognostic studies. Two thoracic pathologists independently classified 80 cases of type A or B3 thymoma and thymic carcinoma according to World Health Organization (WHO) classification. Ki-67 labeling index (LI) was used to identify cutoff points between WHO types. Recursive partitioning (Rpart) and ad hoc methods separated the data points. The pathologists agreed on type A (n = 31), type B3 (n = 21), and thymic carcinoma (n = 14). Ki-67 LI differed between types A and B3 (P <.001) and between thymic carcinoma and type A (P <.001) or type B3 (P =.001). Mitotic activity differed between thymic carcinoma and type A (P <.001) or type B3 (P <.001). Rpart revealed Ki-67 LI greater than 14.0% only in thymic carcinoma; cases with Ki-67 LI less than 5.1% did not represent thymic carcinoma. Ad hoc analysis showed Ki-67 LI greater than or equal to 13.5% represents thymic carcinoma; only type A had Ki-67 LI less than 2%. The pathologists disagreed on histologic type in 14 cases. In 11 of 14 cases with available Ki-67, the Rpart method predicted the WHO type; in 7 of 14 cases, the ad hoc method predicted the WHO type. In conclusion, Ki-67 LI is helpful in differentiating thymic epithelial neoplasms, with Ki-67 LI less than 2% and greater than or equal to 13.5% distinguishing type A thymoma and thymic carcinoma, respectively.

Original languageEnglish (US)
Pages (from-to)17-25
Number of pages9
JournalHuman Pathology
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Thymoma
Thymus Neoplasms
Glandular and Epithelial Neoplasms
Thorax

Keywords

  • Bcl-2
  • Ki-67 labeling index
  • Mitoses
  • Thymic carcinoma
  • Thymoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. / Roden, Anja; Yi, Eunhee S.; Jenkins, Sarah M.; Donovan, Janis L.; Cassivi, Stephen D.; Garces, Yolanda Isabel; Marks, Randolph Stuart; Aubry, Marie Christine.

In: Human Pathology, Vol. 46, No. 1, 01.01.2015, p. 17-25.

Research output: Contribution to journalArticle

Roden, Anja ; Yi, Eunhee S. ; Jenkins, Sarah M. ; Donovan, Janis L. ; Cassivi, Stephen D. ; Garces, Yolanda Isabel ; Marks, Randolph Stuart ; Aubry, Marie Christine. / Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. In: Human Pathology. 2015 ; Vol. 46, No. 1. pp. 17-25.
@article{65f8aecb71ac4f22a5e9423852a83f66,
title = "Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas",
abstract = "The prognostic importance of histologic classifications of thymic epithelial neoplasms is controversial. Evidence suggests that difficulties in reproducibility affect prognostic studies. Two thoracic pathologists independently classified 80 cases of type A or B3 thymoma and thymic carcinoma according to World Health Organization (WHO) classification. Ki-67 labeling index (LI) was used to identify cutoff points between WHO types. Recursive partitioning (Rpart) and ad hoc methods separated the data points. The pathologists agreed on type A (n = 31), type B3 (n = 21), and thymic carcinoma (n = 14). Ki-67 LI differed between types A and B3 (P <.001) and between thymic carcinoma and type A (P <.001) or type B3 (P =.001). Mitotic activity differed between thymic carcinoma and type A (P <.001) or type B3 (P <.001). Rpart revealed Ki-67 LI greater than 14.0{\%} only in thymic carcinoma; cases with Ki-67 LI less than 5.1{\%} did not represent thymic carcinoma. Ad hoc analysis showed Ki-67 LI greater than or equal to 13.5{\%} represents thymic carcinoma; only type A had Ki-67 LI less than 2{\%}. The pathologists disagreed on histologic type in 14 cases. In 11 of 14 cases with available Ki-67, the Rpart method predicted the WHO type; in 7 of 14 cases, the ad hoc method predicted the WHO type. In conclusion, Ki-67 LI is helpful in differentiating thymic epithelial neoplasms, with Ki-67 LI less than 2{\%} and greater than or equal to 13.5{\%} distinguishing type A thymoma and thymic carcinoma, respectively.",
keywords = "Bcl-2, Ki-67 labeling index, Mitoses, Thymic carcinoma, Thymoma",
author = "Anja Roden and Yi, {Eunhee S.} and Jenkins, {Sarah M.} and Donovan, {Janis L.} and Cassivi, {Stephen D.} and Garces, {Yolanda Isabel} and Marks, {Randolph Stuart} and Aubry, {Marie Christine}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2014.10.001",
language = "English (US)",
volume = "46",
pages = "17--25",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas

AU - Roden, Anja

AU - Yi, Eunhee S.

AU - Jenkins, Sarah M.

AU - Donovan, Janis L.

AU - Cassivi, Stephen D.

AU - Garces, Yolanda Isabel

AU - Marks, Randolph Stuart

AU - Aubry, Marie Christine

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The prognostic importance of histologic classifications of thymic epithelial neoplasms is controversial. Evidence suggests that difficulties in reproducibility affect prognostic studies. Two thoracic pathologists independently classified 80 cases of type A or B3 thymoma and thymic carcinoma according to World Health Organization (WHO) classification. Ki-67 labeling index (LI) was used to identify cutoff points between WHO types. Recursive partitioning (Rpart) and ad hoc methods separated the data points. The pathologists agreed on type A (n = 31), type B3 (n = 21), and thymic carcinoma (n = 14). Ki-67 LI differed between types A and B3 (P <.001) and between thymic carcinoma and type A (P <.001) or type B3 (P =.001). Mitotic activity differed between thymic carcinoma and type A (P <.001) or type B3 (P <.001). Rpart revealed Ki-67 LI greater than 14.0% only in thymic carcinoma; cases with Ki-67 LI less than 5.1% did not represent thymic carcinoma. Ad hoc analysis showed Ki-67 LI greater than or equal to 13.5% represents thymic carcinoma; only type A had Ki-67 LI less than 2%. The pathologists disagreed on histologic type in 14 cases. In 11 of 14 cases with available Ki-67, the Rpart method predicted the WHO type; in 7 of 14 cases, the ad hoc method predicted the WHO type. In conclusion, Ki-67 LI is helpful in differentiating thymic epithelial neoplasms, with Ki-67 LI less than 2% and greater than or equal to 13.5% distinguishing type A thymoma and thymic carcinoma, respectively.

AB - The prognostic importance of histologic classifications of thymic epithelial neoplasms is controversial. Evidence suggests that difficulties in reproducibility affect prognostic studies. Two thoracic pathologists independently classified 80 cases of type A or B3 thymoma and thymic carcinoma according to World Health Organization (WHO) classification. Ki-67 labeling index (LI) was used to identify cutoff points between WHO types. Recursive partitioning (Rpart) and ad hoc methods separated the data points. The pathologists agreed on type A (n = 31), type B3 (n = 21), and thymic carcinoma (n = 14). Ki-67 LI differed between types A and B3 (P <.001) and between thymic carcinoma and type A (P <.001) or type B3 (P =.001). Mitotic activity differed between thymic carcinoma and type A (P <.001) or type B3 (P <.001). Rpart revealed Ki-67 LI greater than 14.0% only in thymic carcinoma; cases with Ki-67 LI less than 5.1% did not represent thymic carcinoma. Ad hoc analysis showed Ki-67 LI greater than or equal to 13.5% represents thymic carcinoma; only type A had Ki-67 LI less than 2%. The pathologists disagreed on histologic type in 14 cases. In 11 of 14 cases with available Ki-67, the Rpart method predicted the WHO type; in 7 of 14 cases, the ad hoc method predicted the WHO type. In conclusion, Ki-67 LI is helpful in differentiating thymic epithelial neoplasms, with Ki-67 LI less than 2% and greater than or equal to 13.5% distinguishing type A thymoma and thymic carcinoma, respectively.

KW - Bcl-2

KW - Ki-67 labeling index

KW - Mitoses

KW - Thymic carcinoma

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=84915750941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915750941&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.10.001

DO - 10.1016/j.humpath.2014.10.001

M3 - Article

C2 - 25455993

AN - SCOPUS:84915750941

VL - 46

SP - 17

EP - 25

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -